JW Lifescience Corporation (KRX: 234080)
South Korea
· Delayed Price · Currency is KRW
11,280
-270 (-2.34%)
Dec 20, 2024, 3:30 PM KST
JW Lifescience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 174,666 | 199,286 | 188,137 | 214,461 | 328,567 | 313,524 | Upgrade
|
Market Cap Growth | -18.00% | 5.93% | -12.27% | -34.73% | 4.80% | -9.79% | Upgrade
|
Enterprise Value | 163,684 | 227,270 | 221,603 | 261,011 | 360,376 | 350,186 | Upgrade
|
Last Close Price | 11280.00 | 12870.00 | 11690.12 | 12803.20 | 18511.00 | 17231.63 | Upgrade
|
PE Ratio | 6.06 | 7.08 | 12.57 | 16.61 | 18.99 | 14.29 | Upgrade
|
Forward PE | - | 11.38 | 11.38 | 11.38 | 11.38 | 12.52 | Upgrade
|
PS Ratio | 0.79 | 0.96 | 1.00 | 1.26 | 1.79 | 1.84 | Upgrade
|
PB Ratio | 1.03 | 1.25 | 1.34 | 1.63 | 2.48 | 2.56 | Upgrade
|
P/TBV Ratio | 1.01 | 1.28 | 1.38 | 1.69 | 2.57 | 2.66 | Upgrade
|
P/FCF Ratio | 3.66 | 6.77 | 31.10 | 19.17 | 10.66 | 19.37 | Upgrade
|
P/OCF Ratio | 3.00 | 5.30 | 13.32 | 7.11 | 7.03 | 12.92 | Upgrade
|
EV/Sales Ratio | 0.74 | 1.10 | 1.17 | 1.54 | 1.96 | 2.06 | Upgrade
|
EV/EBITDA Ratio | 3.10 | 4.90 | 5.27 | 6.27 | 6.97 | 8.46 | Upgrade
|
EV/EBIT Ratio | 4.41 | 7.36 | 8.18 | 9.19 | 9.13 | 11.77 | Upgrade
|
EV/FCF Ratio | 3.43 | 7.72 | 36.63 | 23.33 | 11.69 | 21.64 | Upgrade
|
Debt / Equity Ratio | 0.26 | 0.29 | 0.48 | 0.35 | 0.28 | 0.36 | Upgrade
|
Debt / EBITDA Ratio | 0.89 | 1.00 | 1.60 | 1.12 | 0.71 | 1.08 | Upgrade
|
Debt / FCF Ratio | 0.94 | 1.57 | 11.11 | 4.15 | 1.19 | 2.76 | Upgrade
|
Asset Turnover | 0.86 | 0.81 | 0.80 | 0.78 | 0.88 | 0.85 | Upgrade
|
Inventory Turnover | 7.30 | 6.80 | 6.53 | 6.38 | 7.63 | 8.00 | Upgrade
|
Quick Ratio | 1.61 | 0.89 | 1.03 | 0.45 | 0.54 | 0.66 | Upgrade
|
Current Ratio | 2.09 | 1.14 | 1.31 | 0.77 | 0.82 | 0.90 | Upgrade
|
Return on Equity (ROE) | 17.97% | 18.78% | 11.01% | 9.78% | 13.56% | 18.92% | Upgrade
|
Return on Assets (ROA) | 8.36% | 7.58% | 7.17% | 8.19% | 11.86% | 9.24% | Upgrade
|
Return on Capital (ROIC) | 10.21% | 9.34% | 8.78% | 10.24% | 14.66% | 11.21% | Upgrade
|
Earnings Yield | 16.50% | 14.12% | 7.95% | 6.02% | 5.27% | 7.00% | Upgrade
|
FCF Yield | 27.35% | 14.76% | 3.22% | 5.22% | 9.38% | 5.16% | Upgrade
|
Dividend Yield | 4.43% | 3.89% | 4.28% | 3.91% | 2.70% | 2.90% | Upgrade
|
Payout Ratio | 26.87% | 27.51% | 51.75% | 61.31% | 45.76% | 36.09% | Upgrade
|
Buyback Yield / Dilution | - | 0.61% | 1.61% | - | - | Upgrade
| |
Total Shareholder Return | 4.43% | 3.89% | 4.89% | 5.51% | 2.70% | 2.90% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.